PER 1.23% 8.0¢ percheron therapeutics limited

next ann:initiation of phase iia trial atl1103, page-15

  1. 18,601 Posts.
    lightbulb Created with Sketch. 4
    an oiler produces a commodity...there will be a guaranteed market for it if it flows

    a biotech can go through phase I, II, III but there is no guarantee of commercial success even if the drug reaches market...look at Biota.

    this isn't a downramp I am just saying I don't think your analogy is quite correct using probabilities of success and it applies across all biotechs.
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.